International Biotechnology Trust Plc

International Biotechnol... (IBT)

Company name:International Biotechnology Trust Plc
EPIC:IBTTrading Currency:GBX
Market Sector:SSC6ISIN:GB0004559349
Market Segment:SSMMShare Type:DE
WWW Address: 25P
 Price Price Change [%] Bid Offer Open High Low Volume
 734.00 0.0 [0.00] 731.00 738.00 - - - 2,019
 Market Cap. [m] Shares In Issue [m] Beta EPS DPS PE Ratio Yield 52-Wks-Range
 299.75 40.84 -0.04 -5.79 24.80 - 3.38 862.00 - 650.00

International Biotechnol... Key Figures

(at previous day's close)
Market Cap.299.75m
Shares In Issue40.84m
Prev. Close734.00
PE Ratio- 
Dividend Yield3.38%
EPS - basic-5.79p
Dividend PS24.80p
Dividend Cover- 
Cash Flow PS-23.39p
Return On Equity (ROE)-0.78%
Operating Margin-181.22%
PEG Factor- 
EPS Growth Rate-3.76%
Dividends PS Growth Rate-11.43%
Net Debt18.49m
Gross Gearing6.21%
Quick Assets0.49m
Net Working Capital-18.33m
Intangibles / Fixed Assets-%
Turnover PS2.78p
Pre-Tax Profit PS-5.03p
Retained Profit PS-28.83p
Cash PS0.79p
Net Cash PS-45.27p
Net Tangible Asset Value PS *695.18p
Net Asset Value PS738.61p
Spread7.00 (0.95%) 

International Biotechnol... Balance Sheet


Share Price Performance

Sample Period HighLow
1 week736.00688.00
4 weeks782.00688.00
12 weeks862.00688.00
1 year862.00650.00

Share Price Chart (5 years)

International Biotechnol... Historic Returns

Period OpenChange%Open Avg.Avg. Daily Vol [m]Total Vol [m]VWAP
1 week715.0019.002.66688.000.24710.63
4 weeks774.00-40.00-5.17688.000.18730.55
12 weeks836.00-102.00-12.20688.000.11769.75
26 weeks830.00-96.00-11.57688.000.10792.85
1 year656.0078.0011.89650.000.09775.73
3 years558.00176.0031.54451.000.07680.18
5 years454.50279.5061.50395.000.06644.78

International Biotechnol... Key Management Ratios

International Biotechnol... Investment Ratios

(Market value analysis) at previous day's close
PQ Ratio- 
PE Ratio- 
Tobin's Q Ratio 1.10 
Tobin's Q Ratio (excl. intangibles)1.10 
Dividend Yield3.38%
Market-to-Book Ratio1.06 
Price-to-Pre-Tax Profit PS-145.86 
Price-to-Retained Profit PS-25.46 
Price-to-Cash Flow PS-31.38 
Price-to-Sales PS264.33 
Price-to-Net Tangible Asset Value PS0.99 
Price-to-Cash PS925.15 
Net Working Capital PS-44.88 
Price Pct to Working Capital PS-16.36%
Earnings Yield-%
Average PE- 
Years in average- 
PE to PE average-%

International Biotechnol... Financial Ratios

(Leverage Ratios)
Debt Ratio-%
Debt-to-Equity Ratio- 
Debt-to-Equity Ratio (excl. Intgbl)- 
Debt-to-Equity Market Value- 
Net Gearing6.11%
Net Gearing (excl. Intangibles)6.11%
Gross Gearing6.21%
Gross Gearing (excl. Intangibles)6.21%
Gearing Under 1 Year6.21%
Gearing Under 1 Year (excl. Intgbl)6.21%
(Liquidity Ratios)
Net Working Capital to Total Assets-6.05%
Current Ratio0.03 
Quick Ratio (Acid Test)0.03 
Liquidity Ratio0.02 
Cash & Equiv/Current Assets66.80%
(Solvency Ratios)
Enterprise Value299.43m
CFO/Attributable Profit- 
Total Debt/Equity Market Value0.06 
Total Debt/Sales16.59 
Total Debt/Pre-Tax Profit-9.15 
Total Debt18.81m
Total Debt/Net Current Assets-1.03%
(Dodds - Graham Ratios)
3 yr Compound Earnings Growth-5.63%
5 yr Compound Earnings Growth-2.67%
10 yr Compound Earnings Growth-%
Earn drops > 5% in 10yrs11 
Beta (60-Mnth)Beta (36-Mnth)

International Biotechnol... Operating Ratios

(Profitability Ratios)
Return On Capital Employed (ROCE)-0.72%
Return On Assets (ROA)-0.82%
Net Profit Margin-196.21%
Assets Turnover0.00 
Return On Equity (ROE)-0.78%
Return On Investment (ROI)-0.85%
Dividend Payout Ratio-%
Plowback Ratio100.00%
Growth from Plowback Ratio-%
Net Income Of Revenues-1,038.10%
(Asset Utilisation Multiples)
Shareholders Equity Turnover0.00 
Fixed Assets Turnover0.00 
Current Assets Turnover0.57 
Net Working Capital Turnover 
Inventory Turnover- 
(Other Operating Ratios)
Total Assets-to-Sales239.67 
Debt Collection Period446.92Days

International Biotechnol... Dividends

Announcement DateTypeCurr.Dividend AmountPeriod StartPeriod EndEx DateRecord DatePayment DateTotal Dividend Amount
08 Jul 2020InterimGBX12.4031/08/201931/08/202016/07/202017/07/202028/08/202024.80
11 Dec 2019InterimGBX12.4028/08/201928/02/202019/12/201920/12/201931/01/2020-
10 Jul 2019InterimGBX14.0031/08/201831/08/201918/07/201919/07/201930/08/201928.00
12 Dec 2018InterimGBX14.0028/08/201828/02/201920/12/201821/12/201831/01/2019-
11 Jul 2018InterimGBX11.5031/08/201731/08/201802/08/201803/08/201831/08/201823.00
12 Dec 2017InterimGBX11.5028/08/201728/02/201804/01/201805/01/201831/01/2018-
12 Jul 2017InterimGBX11.5031/08/201631/08/201703/08/201704/08/201731/08/201723.00
13 Dec 2016InterimGBX11.5028/08/201628/02/201705/01/201706/01/201731/01/2017-

International Biotechnol... Fundamentals

 31 Aug 2017 (GBP)31 Aug 2018 (GBP)31 Aug 2019 (GBP)31 Aug 2020 (GBP)
pre tax profit-1.83--2.54--2.02--2.06-181.22%m
attributable profit-1.90--2.59--2.11--2.23-196.21%m
retained profit-10.54--2.59--12.73--11.77-1,038.10%m
eps - basic (p)-5.07 -6.89 -5.58 -5.79 
eps - diluted (p)-5.07 -6.89 -5.58 -5.79 
dividends per share23.00 23.00 28.00 24.80 

International Biotechnol... Balance Sheet

 31 Aug 2017 (GBP)31 Aug 2018 (GBP)31 Aug 2019 (GBP)31 Aug 2020 (GBP)
 31 Aug 2017 (GBP)31 Aug 2018 (GBP)31 Aug 2019 (GBP)31 Aug 2020 (GBP)
fixed assets fixed assets--%--%--%--%m
intangibles intangibles--%--%--%--%m
fixed investments fixed investments269.3798.91%263.0299.93%237.3698.55%302.2299.84%m
current assets - other current assets - other--%--%--%--%m
stocks stocks--%--%--%--%m
debtors debtors2.841.04%0.050.02%2.621.09%0.160.05%m
cash & securities cash & securities0.130.05%0.140.05%0.890.37%0.320.11%m
creditors - short creditors - short19.697.23%0.740.28%1.280.53%18.816.21%m
creditors - long creditors - long--%--%--%--%m
creditors - other creditors - other--%--%--%--%m
subordinated loans subordinated loans--%--%--%--%m
insurance funds insurance funds--%--%--%--%m
ord cap, reserves ord cap, reserves252.6592.77%262.4799.72%239.5899.47%283.9093.79%m
prefs, minorities prefs, minorities--%--%--%--%m
NAV Basic672.88 699.04 623.94 738.61 
NAV Diluted672.88 699.04 623.94 738.61 

International Biotechnol... Cash Flow Statement

31 Aug 2017 (GBP)31 Aug 2018 (GBP)31 Aug 2019 (GBP)31 Aug 2020 (GBP)
Operating CF14.7116.176.47-9.55m
Pre-Financing CF14.7116.176.47-9.55m
Retained CF5.466.031.12-18.66m

International Biotechnol... Brokers

Arbuthnot Securities LimitedMarket Maker(MMF)Broker/DealerARBTALESGB31MKT
J.P. Morgan Cazenove LimitedMarket Maker(MMF)Broker/DealerCAZRCAZEGB2L
Cenkos Securities PlcMarket Maker(MMF)Broker/DealerCNKSCNKOGB21
Collins Stewart Europe LimitedMarket Maker(MMF)Broker/DealerCSCSCSTEGB21
Canaccord Genuity LimitedMarket Maker(MMF)Broker/DealerCANAHOARGB21001
J.P. Morgan Securities LtdMarket Maker(MMF)Broker/DealerJPMSJPMSGB2L
Merrill Lynch InternationalMarket Maker(MMF)Broker/DealerMLSBSNCSGB2LBIC
UBS AGMarket Maker(MMF)Broker/DealerUBS.UBSWGB2LEQU
Winterflood Securities LtdMarket Maker(MMF)Broker/DealerWINSWNTSGB2LBIC
ADVFN Advertorial
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20210419 07:24:21